|
1
|
Nakamaru Y, Furuta Y, Takagi D, Oridate N
and Fukuda S: Preservation of the nasolacrimal duct during
endoscopic medial maxillectomy for sinonasal inverted papilloma.
Rhinology. 48:452–456. 2010.PubMed/NCBI
|
|
2
|
Myers EN, Fernau JL, Johnson JT, Tabet JC
and Barnes EL: Management of inverted papilloma. Laryngoscope.
100:481–490. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Furuta Y, Shinohara T, Sano K, Nagashima
K, Inoue K, Tanaka K and Inuyama Y: Molecular pathologic study of
human papillomavirus infection in inverted papilloma and squamous
cell carcinoma of the nasal cavities and paranasal sinuses.
Laryngoscope. 101:79–85. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kinoshita T, Hanazawa T, Nohata N, Okamoto
Y and Seki N: The functional significance of microRNA-375 in human
squamous cell carcinoma: Aberrant expression and effects on cancer
pathways. J Hum Genet. 57:556–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Christensen BC, Moyer BJ, Avissar M,
Ouellet LG, Plaza SL, McClean MD, Marsit CJ and Kelsey KT: A let-7
microRNA-binding site polymorphism in the KRAS 3′UTR is associated
with reduced survival in oral cancers. Carcinogenesis.
30:1003–1007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hatakeyama H, Cheng H, Wirth P, Counsell
A, Marcrom SR, Wood CB, Pohlmann PR, Gilbert J, Murphy B, Yarbrough
WG, et al: Regulation of heparin-binding EGF-like growth factor by
miR-212 and acquired cetuximab-resistance in head and neck squamous
cell carcinoma. PLoS One. 5:e127022011. View Article : Google Scholar
|
|
8
|
Syrjänen S: Human papillomavirus (HPV) in
head and neck cancer. J Clin Virol. 32 Suppl 1:S59–S66. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
zur Hausen H: Papillomaviruses causing
cancer: Evasion from host-cell control in early events in
carcinogenesis. J Natl Cancer Inst. 92:690–698. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Syrjänen K and Syrjanen S: Detection of
human papillomavirus in sinonasal carcinoma: Systematic review and
meta-analysis. Hum Pathol. 44:983–991. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagata Y, Lan KH, Zhou X, Tan M, Esteva
FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, et al: PTEN
activation contributes to tumor inhibition by trastuzumab and loss
of PTEN predicts trastuzumab resistance in patients. Cancer Cell.
6:117–127. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Courthod G, Franco P, Palermo L, Pisconti
S and Numico G: The role of microRNA in head and neck cancer:
Current knowledge and perspectives. Molecules. 19:5704–5716. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stambolic V, MacPherson D, Sas D, Lin Y,
Snow B, Jang Y, Benchimol S and Mak TW: Regulation of PTEN
transcription by p53. Mol Cell. 8:317–325. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pedrero JM, Carracedo DG, Pinto CM,
Zapatero AH, Rodrigo JP, Nieto CS and Gonzalez MV: Frequent genetic
and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head
and neck squamous cell carcinoma. Int J Cancer. 114:242–248. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
da Costa AA, D'Almeida Costa F, Ribeiro
AR, Guimarães AP, Chinen LT, Lopes CA and de Lima VC: Low PTEN
expression is associated with worse overall survival in head and
neck squamous cell carcinoma patients treated with chemotherapy and
cetuximab. Int J Clin Oncol. 20:282–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stransky N, Egloff AM, Tward AD, Kostic
AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C,
McKenna A, et al: The mutational landscape of head and neck
squamous cell carcinoma. Science. 333:1157–1160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Agrawal N, Frederick MJ, Pickering CR,
Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et
al: Exome sequencing of head and neck squamous cell carcinoma
reveals inactivating mutations in NOTCH1. Science. 333:1154–1157.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bian Y, Hall B, Sun ZJ, Molinolo A, Chen
W, Gutkind JS, Waes CV and Kulkarni AB: Loss of TGF-β signaling and
PTEN promotes head and neck squamous cell carcinoma through
cellular senescence evasion and cancer-related inflammation.
Oncogene. 31:3322–3332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Squarize CH, Castilho RM, Abrahao AC,
Molinolo A, Lingen MW and Gutkind JS: PTEN deficiency contributes
to the development and progression of head and neck cancer.
Neoplasia. 15:461–471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schwerer MJ, Sailer A, Kraft K, Baczako K
and Maier H: Patterns of p21 (waf1/cip1) expression in
non-papillomatous nasal mucosa, endophytic sinonasal papillomas and
associated carcinomas. J Clin Pathol. 54:871–876. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sham CL, To KF, Chan PK, Lee DL, Tong MC
and van Hasselt CA: Prevalence of human papillomavirus,
Epstein-Barr virus, p21, and p53 expression in sinonasal inverted
papilloma, nasal polyp, and hypertrophied turbinate in Hong Kong
patients. Head Neck. 34:520–533. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim SG, Lee OY, Choi JW, Park YH, Kim YM,
Yeo MK, Kim JM and Rha KS: Pattern of expression of cell
cycle-related proteins in malignant transformation of sinonasal
inverted papilloma. Am J Rhinol Allergy. 25:75–81. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoon AR, Gao R, Kaul Z, Choi IK, Ryu J,
Noble JR, Kato Y, Saito S, Hirano T, Ishii T, et al: MicroRNA-296
is enriched in cancer cells and downregulates p21WAF1 mRNA
expression via interaction with its 3′ untranslated region. Nucleic
Acids Res. 39:8078–8091. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Würdinger T, Tannous BA, Saydam O, Skog J,
Grau S, Soutschek J, Weissleder R, Breakefield XO and Krichevsky
AM: miR-296 regulates growth factor receptor overexpression in
angiogenic endothelial cells. Cancer Cell. 14:382–393. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong L, Han Y, Zhang H, Li M, Gong T, Sun
L, Wu K, Zhao Q and Fan D: The prognostic and chemotherapeutic
value of miR-296 in esophageal squamous cell carcinoma. Ann Surg.
251:1056–1063. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu X, Chen Q, Yan J, Wang Y, Zhu C, Chen
C, Zhao X, Xu M, Sun Q, Deng R, et al: MiRNA-296-3p-ICAM-1 axis
promotes metastasis of prostate cancer by possible enhancing
survival of natural killer cell-resistant circulating tumour cells.
Cell Death Dis. 4:e9282013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chung CH, Parker JS, Karaca G, Wu J,
Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X,
et al: Molecular classification of head and neck squamous cell
carcinomas using patterns of gene expression. Cancer Cell.
5:489–500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hatakeyama H, Kondo T, Fujii K, Nakanishi
Y, Kato H, Fukuda S and Hirohashi S: Protein clusters associated
with carcinogenesis, histological differentiation and nodal
metastasis in esophageal cancer. Proteomics. 6:6300–6316. 2006.
View Article : Google Scholar : PubMed/NCBI
|
